Over 180,000 courses of oral COVID-19 treatment Paxlovid purchased by CECC arrive in Taiwan

On April 22, the Central Epidemic Command Center (CECC) pointed out that Taiwan had signed a contract with Pfizer to procure 700,000 courses of the oral drug Paxlovid earlier this year, and more than 180,000 courses have arrived in Taiwan recently; deliveries of this procurement of Paxlovid are expected to be completed in the second quarter.

發佈日期 2022/4/22